Research on cancer development now firmly positions chronic inflammation as a central factor driving tumor initiation, malignant progression, and ...

The field of cancer research has increasingly focused on the intricate interplay between regulated cell death (RCD) pathways and the immune microenvironment in tumor progression and treatment.

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor ...

A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered ...

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the ...